Open Access 01-12-2018 | Letter to the Editor
Normocomplementaemic urticarial vasculitis: effective treatment with omalizumab
Published in: Clinical and Translational Allergy | Issue 1/2018
Login to get accessAbstract
We report two patients with normocomplementaemic urticarial vasculitis with impressive response to omalizumab. This contrasts recent reports on hypocomplementaemic urticarial vasculitis syndrome, highlighting the need for clinical trials of omalizumab in normocomplementaemic urticarial vasculitis.